Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer

References

Page 1

	Year	Citations
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature Andrea Köhrmann, Ulrike Kämmerer, Michaela Kapp, BMC Cancer	2009	385
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis Michael Herman, Galina K. Sukhova, Walter Kisiel, Journal of Clinical Investigation Vascular DiseaseNovel InhibitorImmunologyPathologyOxidative Stress	2001	228
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma Norihiro Sato, Antony R. Parker, Noriyoshi Fukushima, Oncogene Cancer ResearchLineage PlasticityPancreatic CancerCommon MechanismEpigenetic Inactivation	2004	174
Inhibitory Properties of a Novel Human Kunitz-Type Protease Inhibitor Homologous to Tissue Factor Pathway Inhibitor Lars C. Petersen, Cindy A. Sprecher, Donald C. Foster, Biochemistry	1996	149
Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential Rita CS Figueira, Luciana Rodrigues Gomes, João Siufi Neto, BMC Cancer	2009	139
Regulation of ProMMP-1 and ProMMP-3 Activation by Tissue Factor Pathway Inhibitor-2/Matrix-Associated Serine Protease Inhibitor C.N. Rao, Sanjeeva Mohanam, Anupama K. Puppala, Biochemical and Biophysical Research Communications Signal TransductionSignaling PathwayCell RegulationPrommp-3 ActivationMedicine	1999	96
Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. Santhi D. Konduri, Navvi Chandrasekar, Jia‐Sheng Rao International Journal of Oncology ImmunologyProstate Cancer CellsTumor BiologyTfpi-2 ProteinOncology	2001	78
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI C.N. Rao, Brian N. Cook, Yueying Liu, International Journal of Cancer	1998	77
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer J. Rollin, Sophie Iochmann, Claire Bléchet, British Journal of Cancer	2005	75
Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer Hisashi Takada, Naoki Wakabayashi, Osamu Dohi, Cancer Genetics and Cytogenetics Tumor BiologyAberrant Promoter HypermethylationGastrointestinal OncologyMedicinePathology	2010	75

Page 1